Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes
Recruiting
Observational Study
Chronic Kidney Disease (CKD)
Hyperkalemia
Hemodialysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Saglik Bilimleri Universitesi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study.
Data will be compared in…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients over 18 years old
2. Chronic kidney disease patients with eGFR \< 60 mL/min/1.73 m²
3. Patients with hyperkalemia detected in the emergency department
4. Patients willing to participate in the study and who sign the consent form
Exclusion Criteria:
1. Patients u…
Contacts